| Shortcuts: 2010 2009 2008 2007 2006 2005 2004 2003 2002 |
|
| 2010 |
| Poster |
“Intra-myocardial administration of JVS-100 promotes cardiac benefit and improves angiogenesis in a porcine model of heart failure” by Joseph M Pastore, Ph.D, Timothy J Miller, Ph.D, Rahul A Aras, Ph.D, and Marc S Penn, Ph.D, MD. - Juventas Therapeutics and Dept. of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic, Cleveland OH |
| Article |
Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration: A Report of the International Society for Cardiovascular Translational Research by Nabil Dib, Philippe Menasche, Jozef J. Bartunek, Andreas M. Zeiher, Andre Terzic, Nicolas A. Chronos, Timothy D. Henry, Nicholas S. Peters, Francisco Fernández-Avilés, Magdi Yacoub, Timothy A. Sanborn, Anthony DeMaria, Richard A. Schatz, Doris A. Taylor, Shmuel Fuchs, Silviu Itescu, Leslie W. Miller, Jonathan H. Dinsmore, George D. Dangas, Jeffrey J. Popma, Jennifer L. Hall, and David R. Holmes, Jr., J. Am coll. Cardiol. Intv. 2010;3;265-275 doi:10.1016/j.jcin.2009.12.013 |
| 2009 |
| Talk |
Transcatheter Cardiovascular Therapeutics, San Francisco, September 2009. Featured in lecture entitled "Clinical Insights to Cell Delivery: Case Demonstrations" by Dr. Alan W. Heldman. |
| Talk |
New Cardiovascular Horizons, New Orleans, LA, June, 2009. Featured in lecture entitled "The role of the cardiologist in myocardial regeneration" by Dr. Juan Pablo Zambrano. |
| Poster |
Cardiac Research Technologies, New York City, March 4-6, 2009. "Three Year Follow-up in an Open-Label, Pilot Study of Transendocardial Autologous Bone Marrow in Chronic Myocardial Infarction using a Helical Needle Catheter" |
| Talk |
The Fifth International Conference on Cell Therapy For Cardiovascular Disease, New York City, January 13-16. Featured in lecture entitled "CD34+ Cells for Combined CHF and Angina" by Gary L. Schaer, M.D. |
| Talk |
Fifth International Conference on Cell Therapy For Cardiovascular Disease, New York City, January 13-16. Featured in lecture entitled "Novel Catheter Techniques in the Acute Setting" by Warren Sherman, M.D. |
| Talk |
Fifth International Conference on Cell Therapy For Cardiovascular Disease, New York City, January 13-16. Featured in lecture entitled "MSCs for Congestive Heart Failure: Surgical and Catheter Applications" by Alan W. Heldman, M.D. |
| 2008 |
| Abstract |
Transcatheter Cardiovascular Therapeutics 2008, Washington D.C., October 12-17. Abstract entitled "Accuracy and Safety of Transendocardial Intramyocardial Injections Using a Fluroscopically-Guided Deflectable Guiding Catheter and a Novel Helix-tipped Dual-Lumen Injection Catheter in a Porcine Model" by Dr. Gary Schaer was presented. |
| Talk |
Transcatheter Cardiovascular Therapeutics 2008, Washington D.C., October 12-17. Featured in talk by Dr. Marc Penn, Director of Technology, Cleveland Clinic Foundation, and founder of AcelleRx, Inc on studies of SDF-1 Plasmid delivered in which dosing in swine showed efficacy at 30 days is positive using BioCardia Helix catheteter. |
| Talk |
Transcatheter Cardiovascular Therapeutics 2008, Washington D.C., October 12-17. Featured in talk by Dr. Joshua Hare, Chief of Cardiology, University of Miami on his talk on Mesenchymal Stem Cells in ST elevated myocardial infarction. |
| Talk |
New Cardiovascular Horizons 2008, New Orleans, LA, September 9-13. Featured in “Combining A Novel Cell Delivery System With Regenerative Therapy – Results Of The TAC-HRT Phase I Trial” by Alan Heldman, M.D. |
 |
Transendocardial Autologous Bone Marrow in Chronic Myocardial Infarction using a Helical Needle Catheter, Two Year Follow-up in an Open-Label, Non-Randomized, Pilot Study (the TABMMI study) Presented at the 2008 World Congress of Cardiology Abstracts, Buenos Aires, Argentina, May 2008. |
|
Transendocardial Autologous Bone Marrow Cells in Chronic Myocardial Infarction using Helical Needle Catheter: Two-Year Followup in an Open-Label, Non-Randomized, Single-Center Pilot Study (the TABMMI study) By Luis M. de la Fuente, M.D., Simon H. Stertzer, M.D., Eduardo Peñaloza, M.D., Julio Argentieri, M.D., Jorge Miano, M.D., Benjamin Koziner, M.D., Christian Bilos, M.D., Licia Battaglia, Ph.D., Graciela Lucero, Ph.D., Jessica Stertzer, Didier Rouy, M.D., Peter A. Altman, Ph.D. Presented at the Cardiovascular Revascularization Therapies (CRT) conference, Washington, D.C., February 12, 2008. |
|
Reporter Gene Imaging Following Percutaneous Delivery in Swine: Moving Toward Clinical Applications. By Martin Rodriguez-Porcel,M.D., Todd J. Brinton, M.D., Ian Y. Chen, MSE, Olivier Gheysens, M.D., Jennifer Lyons, Fumiaki Ikeno, M.D., Jürgen K. Willmann, M.D., Lily Wu, M.D., Ph.D., Joseph C. Wu, M.D., Ph.D., Alan C. Yeung, M.D., Paul Yock, M.D., and Sanjiv J. Gambhir, M.D., Ph.D. Published in the Journal of the American College of Cardiology, February 5, 2008. |
|
| 2007 |
| Poster |
American Heart Association Council on Basic Cardiovascular Sciences, July 30-Aug 2, Keystone, CO: "Transendocardial Catheter Delivery of Artificial Biopolymer Matrices for Enhanced Cell Retention in Cardiovascular Cell Based Therapy" |
|
Transendocardial autologous bone marrow in chronic
myocardial infarction using a helical needle catheter:
1-year follow-up in an open-label, nonrandomized,
single-center pilot study (the TABMMI study) - American Heart Journal, July 2007 |
| Poster |
The
Stem Cell Meeting, March 2007, San Francisco, CA: “Transendocardial
Autologous Bone Marrow Cells in Chronic Myocardial Infarction
Using Helical Needle Catheter, Six Month Follow-up in an Open-Label,
Non-Randomized, Single-Center Pilot Study of an Adult Stem Cell
Stimulation Program (the TABMMI Study)” by Luis De La Fuente,
et. al. |
| Invited Talk |
Percutaneous Endovascular Therapeutics,
April 2007, Buenos Aires, Argentina: “Percutaneous Cardiovascular
Cell Therapy” |
| Talk |
2nd
Annual Symposium on Cardiovascular Cell Therapy 2007: Featured
in ‘Clinical Studies II: Chronic Left Ventricular Dysfunction “Bone
Marrow Mononuclear Cells: The Focus – CHF Study” by
Dr. Emerson Perin |
|
| 2006 |
|
Six Month Follow-up after Transendocardial Autologous Fractionated Bone Marrow Shows Increased Ejection Fraction in Patients with Ventricular Dysfunction After Chronic Myocardial Infarction, an Open-Label, Non-Randomized, Single-Center Study (the TABMMI study) |
|
Catheter-based delivery of cells to the heart
|
|
Percutaneous delivery and non-invasive imaging of gene and cell therapy in a
porcine model |
| Talk |
Transcatheter Cardiovascular
Therapeutics 2006: Featured in “Novel Myocardial
Preservation Therapies” in Plenary Session 15: Interventional
Hot Topics V by Dr. Bill O’Neil |
| Talk |
Transcatheter Cardiovascular
Therapeutics 2006: Featured in “Isolation and
Potential of Cardiac-Derived Stem Cells” in Session
on Myocardial Repair Strategies: From Local Responses to
Cell Therapy to Tissue Engineering by Dr. Joshua Hare. |
| Talk |
Transcatheter Cardiovascular
Therapeutics 2006: Featured in “Cell Retention” Routes
of Cell Delivery by Dr. Dara L. Kraitchman. |
|
| 2005 |
|
Coronary intervention, Vol. 1 No. 3 2005, pp. 95-97 (Japanese) |
|
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction, PNAS, Aug., 2005 |
|
| 2004 |
|
Cardiac Repair with Mesenchymal Stem Cells following Myocardial Infarction
in Pigs |
 |
American Heart Association Scientific Sessions 2004: Featured
in: "Overview of Cell Based Therapies," by Dr. Joshua
Hare, Baltimore, MD. |
|
Transcatheter Cardiovascular Therapeutics 2004: Featured
in “Intracoronary vs. Percutaneous Endomyocardial Delivery
of Porcine Mesenchymal Stem Cells to Areas of Myocardial Infarction,” by
Dr. Eric Price, Stanford University. |
|
| 2003 |
|
In Vivo Magnetic Resonance Imaging of Mesenchymal Stem
Cells in Myocardial Infarction |
|
Percutaneous Endocardial Versus Selective Coronary Venous Cellular Delivery: Comparison of Transplant Efficiency, Distribution, and Efficacy in Reducing Infarct Size and Improving Myocardial Function |
|
Catheter Based Percutaneous Cardiomyoplasty Using Allogenic Bone Marrow Derived Mesenchymal Stem Cells |
|
How Well Does A Helical Needle Catheter Deliver FGF-2? |
|
Intramyocardial Pharmacokinetics of Cell Sized Particles after Local Transendocardial Delivery in Swine |
|
Exploring Heart Lymphatics in Local Drug Delivery |
|
| 2002 |
|
The Helical Infusion Catheter: First Clinical Evaluation for Local Intramyocardial Delivery of Therapeutics |
|
Preparation and Administration of Biodegradable Drug Delivery Microspheres into Porcine Myocardium with a Helical Injection Catheter |
|
Interventional Cellular Cardiomyoplasty by Transendocardial Implantation of Mesenchymal Stem Cells |
 |
Delivery of Plasmid to the Myocardium Using Direct Injection Via Needle or Helical Needle-Catheter |
|
Percutaneous Endocardial Infusion of Plasmids Using Helical Needle Catheter |
|
| 2001 |
|
Percutaneous Intramyocardial Delivery is an Efficient Modality for Local Myocardial Treatment |
|
Transcatheter Delivery of Therapeutic Formulations For Percutaneous Intramyocardial Delivery |
|
Enhanced Local Uptake of Genetic Material Through Intramyocardial Electroporation with Helix Infusion Electrode |
|
Evaluation of the Percutaneous Intramyocardial Injection for Local Myocardial Treatment |
|
| 2000 |
|
Feasibility Studies of Percutaneous Mammalian Cell Delivery for Local Myocardial Treatment |
